Cornell Biotech Startups
A directory of 130 startups founded by Cornell University alumni in biotechnology, therapeutics, and pharmaceuticals, each listed with its founders, stage, and links. Compiled and updated by Big Red AI.
130 listed
-
-
-
Gabriel Otte ’11 · South San Francisco, CABlood test to detect colorectal cancer -
-
-
-
Robert Hariri, MD PhD ’87 · Florham Park, NJBiotech cellular medicines -
Geneoscopy Series CAndrew Barnell ’11, Erica Barnell ’13 · Saint Louis, MOColorectal cancer screening -
Ceribell Series CXingjuan Chao, PhD ’05 · Mountain View, CAPoint-of-care EEG for seizure triage and treatment optimization -
Tiny Health Series ACheryl Yeoh ’06 · Walnut Creek, CAMicrobiome tests for mother/baby's gut health insights -
-
Howard Berman, MD ’01 · Houston, TXTherapeutics with regulatory T cells -
-
Rachel McMinn ’95 · New York, NYGenetic medicine for neurological diseases -
Jeffrey Bluestone, PhD ’80 · South San Francisco, CAT cell therapies for autoimmune and inflammatory diseases -
-
-
Jonathan Javitt, MD ’82 · Wilmington, DETherapeutic for bipolar depression -
-
Kanvas Biosciences Series AHao Shi, PhD ’20, Iwijn De Vlaminck, Professor · Monmouth Junction, NJGut microbiome for therapeutics -
-
Obsidian Therapeutics Series CVic Myer ’89, Jeffrey Trigilio ’06 · Cambridge, MACell and gene therapies -
-
-
-
-
Ashot Papoyan, PhD ’06 · South San Francisco, CABiology computational analysis for drug development -
Rezo Therapeutics Series AGeorge Scangos ’70 · South San Francisco, CAMapping biological networks for drug discovery -
OnCusp Therapeutics Series ABing Yuan, MBA ’02, Eric Slosberg ’91 · New York, NYPipeline of oncology therapeutics -
Christopher Moxham ’89 · Palo Alto, CADrug-gene atlas for drug discovery -
-
Tim Fischell ’77 · Wakefield, MAHypertension medical device targeting nerves -
-
Intelligencia AI Series AVangelis Vergetis ’01 · New York, NYMachine learning for drug development -
Clarametyx Biosciences Series ACharles McOsker, PhD ’82 · Columbus, OHBiologic therapies for bacterial infections -
Soufflé Therapeutics Series ASusan Langer Denner ’13, Robert Langer ’70 · Watertown, MACell-specific therapeutics -
Volastra Therapeutics Series ALewis Cantley, PhD ’75, Olivier Elemento, Professor · New York, NYCancer therapies targeting chromosomal instability -
-
-
-
Dina Burkitbayeva ’10 · San Francisco, CAPsychedelic therapeutics biotech platform -
Kuehnle Agrosystems Series AAdelheid Kuehnle, PhD ’88 · Honolulu, HIAlgae and botanical product ingredients -
-
-
XyloCor Therapeutics Series BRonald Crystal, Professor · King Of Prussia, PAGene therapy for cardiovascular diseases -
-
-
-
Celsius Therapeutics Series BJeffrey Bluestone, PhD ’80 · Cambridge, MAPrecision genomics and therapeutics -
Sensorium Therapeutics Series ADick Simon ’75 · Boston, MAPsychoactive medicines for mental health -
-
Ciba Health Series AInnocent Clement, MBA ’20, Roger Chahine, MBA ’20 · New York, NYValue-based care delivery model -
-
-
Function Oncology Series ASrinath Sampath ’99, MD ’07 · San Diego, CAPrecision medicine for oncology -
David Campbell, PhD ’90 · La Jolla, CAImmunotherapy to fight tumors -
-
-
Leontis Teryazos ’65 · San Diego, CAmRNA therapeutic platform -
Lara Sullivan ’94 · Stamford, CTOncology therapeutics pipeline -
Kursad Araz, PhD ’10 · San Francisco, CAInstruments for protein measurement -
Jim Rotolo, PhD ’07 · Scarsdale, NYPeptide therapeutics for oncology -
Isaac Ciechanover, MD ’00 · South San Francisco, CAT-cell immunotherapy -
Christopher Murphy ’78, DVM ’83, PhD ’84 · Madison, WIClinical trial endpoint services provider -
-
-
-
-
-
Light Horse Therapeutics Series ABenjamin Neel, MD ’83 · San Diego, CAGene editing for drug discovery -
Larkspur Biosciences Series ALewis Cantley, PhD ’75 · Watertown, MAPrecision immunotherapies to outsmart cancer -
-
Detlef Sarbok, MMH ’09 · Columbus, OHPharmacy claims monitoring software -
Brian Wong, MD ’01 · South San Francisco, CAImmunology therapeutic for inflammation and cancer -
Centerline Biomedical Series BVikash Goel ’01, MS ’05 · Cleveland, OHNavigation device for interventional surgery -
-
-
-
-
Matthew DeLisa, Professor, David Putnam, Professor · Lowell, MAImmunity therapy -
Halo Labs Series CBernardo Cordovez, PhD ’10, David Erickson, Professor · Philadelphia, PAProtein therapeutic measurement device -
David Chang ’92 · South San Francisco, CACAR-T for cancer and autoimmune diseases -
Garry Nolan ’83 · Marlborough, MASpatial phenotyping for biology -
Harvey Tian, PhD ’17 · Ithaca, NYSimplified preparation of DNA for sequencing -
-
Laura Towart, PhD ’07 · United KingdomPersonalized cancer therapeutics platform -
-
Johan Kers, PhD ’05 · Portland, ORRecycle plastics with enzymes -
Samuel Lai ’03 · Carrboro, NCTreatment of acute respiratory infections -
-
Bruce German, PhD ’83 · Davis, CAMilk-inspired therapies for infectious diseases -
Aaron Friedman ’05 · Emeryville, CATherapeutics to treat brain disease -
-
-
-
-
-
Joseph Amprey, PhD ’04 · Potomac, MDTreatments for neglected diseases -
-
Brian Strem ’01 · Encinitas, CATherapeutics for ophthalmic infectious diseases -
Sasank Vemulapati, PhD ’19, Li Jiang, PhD ’14 · Bethesda, MDPlasma collection at home -
-
Mxt Biotech Series AAram Chung, PhD ’11 · South KoreaMicrofluidic platforms for cell engineering and immunotherapies -
-
Mango Materials Series BMolly Morse ’03 · Redwood City, CAConvert methane into eco-friendly plastics -
-
-
LunaMicro Pre-SeedNate Robinson, PhD ’00 · SwedenClothing fabric for sweat and moisture management -
-
-
-
Jacob Roberts ’14 · San Francisco, CAMicrobes extract lithium from waste -
-
Brian Magierski ’93 · SwitzerlandCrowdsource brain health solutions -
-
-
Attest Laboratories Pre-SeedDavid O’Brien, MS ’93 · CanadaPoint-of-care testing of metabolite biomarkers -
Forage Evolution SeedBryce Brownfield, PhD ’23, Cameron Kitzinger ’22, David Specht, PhD ’21 · Ithaca, NYSynthetic biology platform -
-
-
-
-
Tom Neyarapally, JD ’02, MBA ’02 · —Computational drug discovery -
-
-
Brian Cali ’89 · Cambridge, MATreatments for gastrointestinal diseases -
-
-
-
